Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients (Q68207066)
Jump to navigation
Jump to search
scientific article published on 01 March 1991
Language | Label | Description | Also known as |
---|---|---|---|
English | Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients |
scientific article published on 01 March 1991 |
Statements
Multiple myeloma: VMCP/VBAP alternating combination chemotherapy is not superior to melphalan and prednisone even in high-risk patients (English)
M Boccadoro
F Marmont
M Tribalto
G Avvisati
A Andriani
T Barbui
M Cantonetti
M Carotenuto
B Comotti
F Dammacco
1 March 1991